Research on the Psychological Status of Patients With HIV-1 Infection
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-80
SponsorShanxi Bethune Hospital
About this trial
The goal of this observational study is to investigate the neuropsychological states of People Living With HIV(PLWH), the prevalence of social and psychological stress adaptation overload and poor episodic memory in PLWH. The main questions it aims to observe are: to observe the prevalence of psychopathic states in PLWH with different viral loads and to compare the effects of different treatments on the prevalence of psychopathic states in PLWH. It is helpful to understand the mental health burden faced by PLWH in China, to improve clinicians' awareness of PLWH's mental and psychological state, and formulate targeted psychological support, treatment and nursing programs.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Receive treatment at the hospital participating in the study; Age range: 18-80 years old, male or female not limited;
Patients who are willing to participate in this clinical study and sign the informed consent form for this study.
Disqualifiers
Pregnant or lactating women; Men and women who are preparing for natural conception or artificial assisted reproduction;
Severe aphasia, physical disability, or any other non neuropsychological factors that may hinder the completion of the assessment;
is currently involved in other research;
Having a tendency towards violence may endanger the safety of others.
Trial population
People Living With HIV
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
All kinds of INSTI medications
DrugAll kinds of INSTI medications, such as Bictegravir/Emtricitabine/Tenofovir alafenamide Fumarate, Dolutegravir/Emtricitabine/Tenofovir alafenamide Fumarate for PLWH
All kinds of conventional medications
DrugAll kinds of conventional medications, such as Abacavir, Efavirenz for PLWH
Treatment groups
500 Participants
are divided into 2 treatment groupsGroup A: Group INSTI1 intervention
Group B: Group CONV1 intervention
Trial outcomes
Primary outcomes
1
The prevalence of AO among different treatment strategies
Observe the differences in the prevalence of AO in PLWH under different treatment strategies
Time frame
2025.8-2026.7Secondary outcomes
1
The changes of Poor EM after the treatment of newly diagnosed PLWH
The changes of Poor EM neuropsychological symptoms in newly diagnosed PLWH compared with the baseline under different treatment regimens
Time frame
2025.8-2026.7Other outcomes
1
The changes of Poor EM after the treatment of treated PLWH
The changes of Poor EM neuropsychological symptoms in treated diagnosed PLWH compared with the baseline under different treatment regimens
Time frame
2025.8-2026.72
The changes in Interpersonal Stress, Work Stress and Daily Stress conditions of PLWH
The changes in Interpersonal Stress, Work Stress and Daily Stress conditions of PLWH compared with the baseline
Time frame
2025.8-2026.7Locations
Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: